Profil
Dr. Steven D.
Reich, MD, is a Chief Medical Officer at Artelo Biosciences, Inc. and a Vice President-Clinical Development at Actuate Therapeutics, Inc. Dr. Reich was previously employed as a Chief Executive & Medical Officer by Anaborex, Inc. He received his graduate degree from the University of Medicine & Dentistry of New Jersey and a doctorate degree from the University of Medicine & Dentistry of New Jersey.
Postes actifs de Steven D. Reich
| Sociétés | Poste | Début |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/04/2018 |
| ACTUATE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Steven D. Reich
| Sociétés | Poste | Fin |
|---|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | President | 31/12/2012 |
Formation de Steven D. Reich
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Anaborex, Inc.
Anaborex, Inc. Medical/Nursing ServicesHealth Services Provides clinical research services | Health Services |
Artelo Biosciences, Inc.
Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
















